Drug Patents owned by Maia Pharms Inc
1. List of Sincalide drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11318100 | MAIA PHARMS INC | Storage stable sincalide formulations |
Apr, 2038
(14 years from now) | |
| US11110063 | MAIA PHARMS INC | Storage stable sincalide formulations |
Apr, 2038
(14 years from now) | |
Do you want to check out SINCALIDE patents from before 2022?
Drugs and Companies using SINCALIDE ingredient
Market Authorisation Date: 22 November, 2022
Treatment: Accelerate the transit of a barium meal through the small bowel, thereby decreasing the time and extent of radiation associated with fluoroscopy and x-ray examination of the intestinal tract; Stimulat...
Dosage: POWDER;INTRAVENOUS
More Information on Dosage
SINCALIDE family patents
5
United States
1
Canada
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic